Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Proteome stroke test could save thousands from brain damage

Tue, 18th Sep 2012 10:57

Medical technology group Proteome Sciences has released details of a study into a blood test which could reduce brain damage in thousands of stroke victims.The group has been collaborating with researchers at the University of Geneva to produce the test which can tell how long ago a stroke actually took place. The exact timing of a stroke has a big influence on the kind of therapy that is used to help patients recover. Treated quickly, the brain damage caused by strokes can be significantly reduced, but as many strokes take place during sleep, it is often difficult to know when the symptoms began.During the study, scientists found one protein, known as GSTP, which showed an almost instantaneous increase in the blood of stroke patients, peaking at three hours after onset and returning to normal levels within around six hours.Extrapolating the results across patients who were admitted to the Geneva Hospital in 2006/7 with suspected stroke, but who did not know when their stroke symptoms started, indicates that testing for GSTP could result in as many as five times more people being eligible for the highly effective "rt-PA" treatment, which can only be used within 4.5 hours of a stroke under UK medical guidelines.The leader of the study, Professor Jean-Charles Sanchez, said: "This is a major step towards improving the management of ischaemic stroke patients using the drugs that we already have available. A simple blood test that matches the therapeutic window of rt-PA is a major advance."Dr Peter Coleman, Deputy Director of Research at The Stroke Association agreed, adding: "When a stroke strikes, time lost is brain lost, meaning that getting to hospital and receiving treatment quickly is absolutely essential. "A test such as this which could be used to quickly diagnose a stroke, possibly before a patient arrives at hospital, could speed up the treatment process and potentially improve outcomes."Proteome's share price rose 3.2% on Tuesday morning and has now gained 63% in the last 12 months.BS

Related Shares

More News
16 May 2024 12:23

IN BRIEF: Proteome Sciences promises AGM return to growth in 2024

Proteome Sciences PLC - London-based protein-focused drug development services provider - Proteome tells annual general meeting on Thursday it is "con...

16 May 2024 10:41

AIM WINNERS & LOSERS: Proteome Sciences eyes return to growth in 2024

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

26 Apr 2024 11:18

Proteome wins GBP500,000 deal to supply mass spectrometry services

(Alliance News) - Proteome Sciences PLC on Friday said it won a contract from an unnamed US biopharmaceutical company to use Proteome's mass spectrome...

26 Apr 2024 10:40

AIM WINNERS & LOSERS: Proteome Sciences rises on GBP500,000 contract

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

26 Apr 2024 09:45

Proteome Sciences secures contract win with US biopharmaceutical firm

(Sharecast News) - Contract proteomics service Proteome Sciences has secured a contract win from a US biopharmaceutical company using the company's ma...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.